Current Oncology Reports

, Volume 10, Issue 1, pp 7–9 | Cite as

Clinical trials report

  • Kevin R. Fox
Article

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Henderson IC, Berry D, Demetri G, et al.: Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol 2003, 21:976–983.PubMedCrossRefGoogle Scholar
  2. 2.
    Berry D, Cirrincione C, Henderson I, et al.: Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 2004, 295:1658–1667.CrossRefGoogle Scholar
  3. 3.
    Kriege M, Brekelmans C, Boetes C, et al.: Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004, 351:427–437.PubMedCrossRefGoogle Scholar
  4. 4.
    Kuhl C, Schrading S, Leutner C, et al.: Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005, 23:8469–8476.PubMedCrossRefGoogle Scholar
  5. 5.
    Saslow D, Boetes C, Burke W, et al.: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007, 57:75–89.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group LLC 2008

Authors and Affiliations

  • Kevin R. Fox

There are no affiliations available

Personalised recommendations